Changes in drug interaction profiles for first-line HIV therapy over the 20 years of the Liverpool Drug Interaction website - Sara Gibbons

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Introduction to HIV Persistence on ART- Denise Hsu, BSc, MBBS, PhD

APACC 2019

European surveillance of HIV drug resistance to NRTI, NNRTI and INSTI in newly diagnosed individuals using next-generation sequencing - Carole Seguin-Devaux

European Meeting on HIV & Hepatitis 2019

High prevalence of the integrase resistance associated accessory mutation L74I in the Russian Federation- Alina Kirichenko

European Meeting on HIV & Hepatitis 2019

Bedaquiline appears to antagonize its own main metabolite’s QTcF interval prolonging effect- Lénaïg Tanneau, PhD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018

Pharmacokinetic-Pharmacodynamic Target Attainment Analysis of Cycloserine in TB Patients- Charles Peloquin, PharmD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018

Longterm Complications of HIV Treatment - Kees Brinkman, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2015

Pushing for Weight Management Bariatric Interventions Benefits and Considerations-Jörn Schattenberg, MD slides

Innovations in NAFLD Care Workshop 2022

Toxic Side Effects of HIV ART and How to Address Them - Hongxin Zhao

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

HIV co-infections from a European Perspective - Jürgen Rockstroh, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2014